Diagnostic service utilizing urinary biomarkers for risk stratification in urinary tract malignancies. Based on clinically validated research models for upper tract urinary carcinoma assessment.
Manufactured by
China
U-GEN Biotechnology is a vertically integrated molecular diagnostics company in Greater China, combining biotechnology and medical expertise across upstream, midstream, and downstream operations. The company utilizes multiplex magnetic bead technology to develop IVD test kits and automated equipment for early tumor screening and chronic disease detection, with laboratories in Beijing, Changsha, Xiamen, and Hong Kong.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
Biopsense Oy
Finland · 1 relevant product
BIOMEX GmbH
Germany · 1 relevant product
in.vent Diagnostica GmbH
Germany · 2 relevant products
Burning Rock Dx Co. Ltd.
China · 1 relevant product
PreceDo Pharmaceuticals Co.Ltd.
China · 1 relevant product
Labcorp
United States · 1 relevant product
DCN Diagnostics
United States · 1 relevant product
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
11 of 11 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
Medical advisory service for cancer risk assessment and early detection strategy development. This service integrates diagnostic testing results with clinical decision support for patient management. The service is provided in collaboration with partner medical institutions.
Biopsense Oy · Finland
Comprehensive diagnostic service utilizing liquid biopsy technology for cancer detection, monitoring, and treatment response evaluation. Supports oncologists in selecting optimal cancer medications and detecting drug resistance through frequent, non-invasive blood sampling.
BIOMEX GmbH · Germany
Comprehensive biomarker identification and quantification service using high-quality human biosamples. Supports diagnostic and life sciences research with detailed analyte assessment.
BioChain (Beijing) Science & Technology. Inc. · China
Clinical laboratory testing service for colorectal cancer early detection using gene methylation methodology. This service is provided through affiliated medical testing laboratories with continuous proficiency certification. The service is integrated into hospital networks and supported by medical insurance coverage.
in.vent Diagnostica GmbH · Germany
Protein array-based biomarker discovery and identification for diagnostic application development.
Burning Rock Dx Co. Ltd. · China
Comprehensive analysis of tumor gene expression patterns to classify cancer subtypes. Guides targeted therapy selection based on transcriptomic signatures.
in.vent Diagnostica GmbH · Germany
Professional biospecimen collection including blood, plasma, fecal, urine, and saliva samples for clinical diagnostic studies.
BioChain (Beijing) Science & Technology. Inc. · China
Comprehensive laboratory testing service for hepatocellular carcinoma early detection and surveillance. This service integrates gene methylation testing with clinical assessment protocols for liver cancer screening. The service is accredited through continuous external quality assessment programs.
PreceDo Pharmaceuticals Co.Ltd. · China
Cancer primary cell biobank service providing engineered and primary cancer cells for preclinical drug development and tumor precision medicine research. Supplies BaF3-based kinase-targeted cell lines and renewable primary cancer cell samples to support antibody-drug conjugate evaluation and immunotherapy drug discovery.
Labcorp · United States
Laboratory analysis of tissue samples to diagnose cancer and other conditions. These biopsies provide pathological evaluation to guide clinical treatment decisions.
DCN Diagnostics · United States
Prospective biospecimen collection and management services supporting diagnostic assay development, clinical validation, and research applications.
© 2026 Suplivia · Home · Browse Products